Day Lucy Insider Trades

Insider Trading History

Track insider trading activity for Day Lucy. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $346k 82,300 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$868k 221,965 shares
$3.91
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 19, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$868k 221,965 shares
$3.91
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $497k 118,363 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.5k 38,000 shares
$1.04
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $323k 77,000 shares
Last Trade
Feb 20, 2026 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.1k 77,000 shares
$1.04
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $317k 75,363 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.57k 5,512 shares
$1.01
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $340k 80,875 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.3k 3,295 shares
$1.00
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $391k 93,000 shares
Last Trade
Feb 26, 2025 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$105k 93,000 shares
$1.13
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $333k 79,170 shares
Last Trade
Feb 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.5k 46,500 shares
$1.13
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $137k 32,670 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.96k 2,957 shares
$1.34
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $231k 55,000 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 55,000 shares
$3.00
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $346k 82,300 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 82,300 shares
$14.29
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $277k 66,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 66,000 shares
$17.28
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 24, 2022 Sale
No data
No data
$4.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up